Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

DRUG:

TAVO412

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Company:

Tavotek

Drug class:

EGFR inhibitor, c-MET inhibitor, VEGF inhibitor

Related drugs:

‹

STAR-LLD SC (0)

cetuximab (347)

osimertinib (301)

erlotinib (235)

gefitinib (194)

panitumumab (123)

lapatinib (107)

neratinib (102)

brigatinib (50)

aumolertinib (39)

amivantamab-vmjw (25)

firmonertinib (14)

mobocertinib (12)

lazertinib (12)

tarloxotinib bromide (7)

nimotuzumab (6)

rociletinib (5)

tomuzotuximab (4)

necitumumab (3)

befotertinib (3)

zorifertinib (3)

ABP 494 (cetuximab biosimilar) (1)

BAY 2927088 (1)

Compound 6a (1)

abivertinib (1)

STI-001 (cetuximab biosimilar) (0)

antroquinonol (0)

zalutumumab (0)

JNJ-26483327 (0)

PF-08046052 (0)

rindopepimut (0)

Undisclosed EGFR inhibitor (0)

cetuximab biosimilar (0)

PF-06747775 (0)

JNJ-64041757 (0)

savolitinib (29)

capmatinib (23)

unecritinib (6)

gumarontinib (5)

JNJ-38877605 (1)

EMD 1204831 (0)

PF-04217903 (0)

recombinant human endostatin (5)

ivonescimab (3)

autologous activated lymphocytes (0)

STAR-LLD SC (0)

›